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INTRODUCTION
Diabetes and hypertension are two non-communicable
diseases that frequently co-exist. Several studies have
shown that raised blood pressure is commoner among
people with diabetes than in the general population.1-3
Both diseases are independent risk factors for
cardiovascular disease (CVD), and when they co-exist
they multiply morbidity and mortality of  CVD.4
Hypertension in diabetes accelerates development and
progression of microvascular and macrovascular
complications in patients with diabetes.5 Among
Nigerians, mortality is increased in diabetic patients with
hypertension compared to normotensive diabetics.6 In
clinical practice, usually patients present first with one
condition followed by later discovery of the other,
although both conditions may simultaneously be
diagnosed at presentation. It is not clear whether the
order of occurrence of hypertension and diabetes is
important such as to make one group differ from the
other clinically or/and metabolically. It is important
to investigate this because, if established differences
exist, there may be implications on morbidity and
mortality.
The objectives of the study therefore, were to find
out the commoner order of discovery of diabetes
and hypertension among patients with co-occurrence
of  diabetes and hypertension, and to determine if  there
are any clinical and metabolic differences between those
first diagnosed with diabetes (herein referred to as
hypertensive diabetics) compared to those first
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Background: There is a high frequency of co-occurrence of diabetes
and hypertension all over the world. Such association results in higher
rate of cardiovascular complications. It is however not clear whether the
order of occurrence distinguishes two different groups of patients and
the implications of  this on morbidity and mortality. The main objective
of  this study is to determine if  there are any clinical and metabolic
differences between those first diagnosed with diabetes (hypertensive
diabetics) compared to those first diagnosed with hypertension (diabetic
hypertensives).
Methodology: A total of 124 patients with co-existent diabetes and
hypertension were consecutively recruited into the study. Demographic
and clinical history was captured on a semi-structured questionnaire,
followed by measurement of  anthropometry and blood pressure. Records
of fasting plasma glucose, urinalysis and electrolytes, urea and creatinine
were obtained from the case records.
Results: There were 83 (66.9%) females and 41 (33.1%) males with mean
age of 61.1 (SD 11.1) years. Sixty or 49.6% was hypertensive diabetics
while 52 or 43% was diabetic hypertensive. The rest had simultaneous
diagnosis of diabetes and hypertension. The diabetic hypertensive
subjects significantly had higher BMI (p= 0.04) while the hypertensive
diabetics group had higher hip/waist ratio (p = 0.01). The diabetic
hypertensive group had higher waist circumference statistically significant
only in women (p = 0.04). Also significantly more people (21 or 42%; p =
0.04) in the diabetic hypertensive group used table salt often. A logistic
regression performed showed that only use of  table salt was
independently associated with order of diagnosis of diabetes or
hypertension.
Conclusion: There could be significant differences in some clinical
characteristics of hypertensive diabetics and diabetic hypertensives, and
use of table salt may be an important risk factor contributing to co-
existence of both conditions.
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diagnosed with hypertension (herein referred to as
diabetic hypertensives).
METHODOLOGY
A cross-sectional study was carried out at the Diabetes
Clinic and Medical Wards of  the University College
Hospital, Ibadan, between June-July, 2009. The
inclusion criteria were being type2 diabetes based on
WHO definition7, having been diagnosed as having
hypertension, and consenting to participate in the study.
A total of 124 subjects were recruited consecutively
into the study. Patients who were moribund and those
who did not give consent were excluded. A semi-
structured pre-tested questionnaire was first
administered to all subjects. Information sought
included demography, duration of  diabetes and
hypertension, list of hypoglycaemic and anti-
hypertensive drugs being used, family history of
diabetes and hypertension, use of table salt (especially
to an already cooked food), history of alcohol and
smoking. The last 3 readings of  their fasting blood
glucose were obtained from their case records and
the average calculated. Last electrolytes, urea and
creatinine done as well as urinalysis (for evidence of
proteinuria) were obtained from the case records. Also
confirmation of  the timing of  diagnosis of
hypertension and diabetes was checked in their case
records. Thereafter the weight, height waist
circumference (WC) and hip circumference of subjects
were measured according to standard procedure. BMI
(Body Mass Index) was calculated as Weight/Height2,
while ratio of hip/waist ratio (HWR) was also
determined. The blood pressure was then measured
in sitting position after 5 minutes of rest using a
mercury sphygmomanometer and in accordance with
standard technique.
Statistical Analysis
Data initially recorded in the questionnaire were
transferred into and analysed using SPSS version 17.
All quantitative variables were expressed as mean and
standard deviation where these were normally
distributed, and as median with range where not
normally distributed. Chi-square was used to analyse
group differences between categorical variables while
independent t-test was used to compare group
differences in continuous variables. Stepwise logistic
regression was done to find out determinant of  being
first diagnosed as hypertensive or diabetic.
RESULTS
There were 83 (66.9%) females and 41 (33.1%) males
with mean age of  61.1 (SD 11.1) years. The median













































Age (in years) 61.1 11.6
Diabetic duration (in years) 6 (0.08-50)
Hypertension duration (in years) 6 (0.08-35)
Fasting Plasma Glucose 138.8 47.9
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was hypertensive diabetics while 52 or 43% was
diabetic hypertensive. The rest had simultaneous
diagnosis of diabetes and hypertension.
Table 3 showed the mean/median values of
electrolytes, urea and creatinine in the subjects. All are
within normal limits according to local reference ranges
in the central laboratory.
In order to determine possible differences between
hypertensive diabetics and diabetic hypertensives, the
two groups were compared in terms of  certain
demographic and clinical parameters. No significant
difference in sexes. Although not statistically significant,
the hypertensive group was older and had poorer
fasting plasma glucose. There was almost no difference
at all in the systolic and diastolic blood pressure of
both groups. As shown in table 4, the diabetic
hypertensive subjects significantly had higher BMI (p=
0.04) while the hypertensive diabetics group had higher
hip/waist ratio (p = 0.01). In the case of waist
circumference, the diabetic hypertensive group had
higher values but this was only statistically significant
in women (p = 0.04). Also significantly more people
(21 or 42%; p = 0.04) in the diabetic hypertensive group
used table salt often.
To determine factors associated with whether diabetic
hypertensive or hypertensive diabetic, a multiple
stepwise logistic regression was carried out. After
adjustment for age, sex, BMI, waist circumference,
family history, use of  alcohol and hypertension, only
use of table salt was independently associated with
being hypertensive diabetics (p= 0.027) or diabetic
hypertensive (p = 0.026).
Order of diagnosis Frequency Percentage
Hypertensive diabetics 60 49.6
Diabetic hypertensives 52 43.0
Simultaneously diagnosed 9 7.4









Proteinuria (Dip-stick) 33 (29.2%)
Table 3: Renal Biochemistry
Attribute Hypertensive diabetics Diabetic hypertensives P value







BMI 26.4 (6.6) 30.4 (11.4) 0.04*









Hip/waist ratio 1.03 (0.1) 1.01 (0.1) 0.01*
Systolic BP 141.9 (21.1) 141.1 (27.0) 0.85
Diastolic BP 82.6 (16.6) 82.5 (17.4) 0.98
Table salt often 14 (23.7%) 21 (42.0%) 0.04*
Took Alcohol 7 (12.1%) 7 (13.7%) 0.80
Smoked 2 (3.4%) 1 (2.0%) 1.00
Took Thiazide 5 (8.3%) 10 (20.0%) 0.76
Proteinuria 15 (27.3%) 9 (18.8%) 0.31
Creatinine 1.20 (0.5) 1.15 (0.4) 0.48
Table 4: Differences between first-diagnosed diabetic and hypertensive
each case. There were sub-optimal blood glucose and
blood pressure control; the mean fasting plasma
glucose (FPG) was 139 (48) mg/dl, the mean systolic
BP and diastolic BP were 141.3 (23) mmHg and 82.7
(16.3) mmHg respectively. The group as a whole was
generally overweight with mean BMI of 28.3 (9.0).
The men had a higher waist circumference above cut-
off point {94.1 (11.6)} while the women had a waist
circumference of  97.4 (11.3). Table 1 shows details
of  the general characteristics of  the subjects.
The median duration of diabetes and hypertension
was each 6 years. As shown in table 2, 60 or 49.6%
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DISCUSSION
In this study, there was a higher frequency of
hypertensive diabetics than diabetic hypertensive
(49.6% versus 43%), while marginal number had both
conditions diagnosed simultaneously. There were some
clinical and metabolic differences between patients
who were first diagnosed with diabetes and those first
diagnosed with hypertension. There were differences
in their age, gender distribution, BMI, hip/waist ratio,
waist circumference, mean FPG, use of  table salt and
proteinuria. However only in terms of  BMI, hip/waist
ratio, waist circumference (females only) and use of
table salt were they significantly different. Moreover
after adjustment for possible confounders, only use
of table salt was independently associated with whether
diabetic hypertensives or hypertensive diabetics.
Hypertension and diabetes frequently coexist. Our
study is probably the first to explore the order of
discovery of these chronic conditions and their
possible clinical, phenotypic and biochemical
differences. Most researches till date usually only report
that both hypertension and diabetes are associated. For
example, in the US population, Movahed and co-
workers using a large database recently reported a
strong association between hypertension and diabetes,
independent of co-morbid conditions8. They also
showed that this association is independent of co-
morbid conditions and was persistent with similar odds
ratio over a period of  10 years. Workers in Nigeria
have reported between 30 to 50% of clinical patients
have associated diabetes and hypertension.9-11
A number of possible reasons have been adduced
for this association. Both share common factors such
as insulin resistance, aging, obesity, use of  thiazide
diuretics in subjects initially with hypertension and
development of nephropathy in those initially with
diabetes, especially type 1.12-13 Diabetes may also be
associated with systolic hypertension secondary to
atherosclerosis.12-13 In addition both conditions are
familial, which is likely to be polygenic in origin,
although the underlying mechanism is still unclear.14-15
Our subject population was relatively older (above 60
years) with a short diabetes and hypertension duration
of 6 years, implying these conditions occurred when
they were in their 5th decade. Obesity and insulin
resistance has consistently been shown to be a precursor
for both hypertension and diabetes.16-17 For unclear
reason, our data showed that the diabetic hypertensive
subjects significantly were heavier and the women had
higher truncal obesity than the hypertensive diabetic
subjects. Kolawole et al 6 had alluded to important
gender differences between normotensive diabetics and
hypertensive diabetics. There is need to investigate this
finding further as the cross-sectional design of our
study limited the knowledge of when the hypertensive
subjects gained the weight- before or after diagnosis
of diabetes, a question better answered by a
longitudinal study. If  anything, higher anthropometry
in hypertensive diabetics may occur, and perhaps would
not be surprising considering that some of them might
have been using weight-promoting hypoglycaemic
agents such as insulin and sulphonylureas before
diagnosis of hypertension. It is however interesting
from the logistic regression analysis that none of the
anthropometric measures had independent association
with whether being diagnosed first with hypertension
or diabetes, implying they could be confounders. The
only factor found to be independently associated was
use of table salt. It is a well established fact that black
patient are particularly sensitive to salt,18-19 hence it was
not surprising to find that diabetic hypertensive subjects
have used table salt more. The role of salt in the
development of diabetes has largely not been
investigated. Isezuo and co-workers20 compared salt
taste perception among Nigerian patients with type 2
diabetes, hypertension and patients with concurrent
hypertension and diabetes. They reported no difference
between these groups. However normotensive diabetic
subjects demonstrated impaired salt taste sensitivity
compared to controls, and so they concluded that salt
taste acuity is impaired in type 2 diabetics and could
be a contributory factor to the high prevalence of
hypertension in the diabetic population. Furthermore
in diabetic patients with hypertension, unrestricted salt
intake could worsen blood pressure control and
attenuate effects of  antihypertensive drugs.21-22
Besides limitation of cross-sectional design and need
for a longitudinal study, a larger sample size is also
needed to confirm, as suggested by our study that
there is a higher frequency of hypertensive diabetics
than diabetic hypertensive (as defined above), and the
role of anthropometry in possible phenotypic
description of the diabetic hypertensives compared
to hypertensive diabetics.
In conclusion, our study, perhaps for the first time at
least in Nigeria, has sensitized physicians that there could
be significant differences in some clinical characteristics
of hypertensive diabetics and diabetic hypertensives,
and use of table salt may be an important risk factor
contributing to co-existence of  both conditions. It will
also be interesting to find out in future studies the
morbidity and mortality patterns of these two groups
of  patients.
Self Disclosure: Nil
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